IO Biotech, Inc.

NASDAQ:IOBT

1.19 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 100.747117.982143.193165.501110.095128.527142.59151.168170.122187.904211.53145.47754.752-3.4053.405-7.846
Short Term Investments 00000000000006.81015.692
Cash and Short Term Investments 100.747117.982143.193165.501110.095128.527142.59151.168170.122187.904211.53145.47754.7523.4053.4057.846
Net Receivables 1.030.9091.1270.9541.1981.0081.5331.0862.072.7892.0912.1192.14501.50
Inventory 000-0.9540.9291.725-1.5335.1846.5688.274-2.0914.0350.21700.3590
Other Current Assets 5.8755.2372.9352.7530.8141.0065.6290.3130.2010.2810.1490.3621.38200.3710
Total Current Assets 107.652124.128147.255168.254113.036132.266148.219157.751178.961199.248221.73851.99358.4963.4055.6357.846
Non-Current Assets:
Property, Plant & Equipment, Net 2.6712.883.1063.1643.363.4343.2343.2522.5062.5190.15500000
Goodwill 0000000000000000
Intangible Assets 0000000000000000
Goodwill and Intangible Assets 0000000000000000
Long Term Investments 0.2680.2680.2680.2680.2680.2680.2680.2680.2680.2680.26800000
Tax Assets 0000000000000000
Other Non-Current Assets 0.8760.8830.0890.8670.8910.8760.0840.8860.910.1360.1270.0450.038-3.4050.018-7.846
Total Non-Current Assets 3.8154.0313.4634.2994.5194.5783.5864.4063.6842.9230.550.0450.038-3.4050.018-7.846
Total Assets 111.467128.159150.718172.553117.555136.844151.805162.157182.645202.171222.28852.03858.53405.6530
Liabilities & Equity:
Current Liabilities:
Account Payables 5.0163.843.8786.6454.4644.264.0042.3454.5412.0873.9282.1661.69600.5220
Short Term Debt 0.6780.6660.6550.6270.6130.5590.5150.4920.4190.345028.2760000
Tax Payables 0000000000000000
Deferred Revenue 00004.833000000-28.2760000
Other Current Liabilities 8.0296.53711.1845.7130.9665.5386.1573.4843.5873.9986.3773.34437.25902.5280
Total Current Liabilities 13.72311.04315.71712.98510.87610.35710.6766.3218.5476.4310.30533.78638.95503.050
Non-Current Liabilities:
Long Term Debt 1.4721.651.8391.9762.1592.2722.2752.3471.9212.048000000
Deferred Revenue Non-Current 0000000000000000
Deferred Tax Liabilities Non-Current 0000000000000000
Other Non-Current Liabilities -00000000000.05900000
Total Non-Current Liabilities 1.4721.651.8391.9762.1592.2722.2752.3471.9212.0480.05937.90637.906037.9060
Total Liabilities 15.19512.69317.55614.96113.03512.62912.9518.66810.4688.47810.36471.69276.861040.9560
Equity:
Preferred Stock 0000000000062.98362.98237.90637.90622.06
Common Stock 0.0660.0660.0660.0660.0290.0290.0290.0290.0290.0290.0290.0280.02800.0280
Retained Earnings -303.965-283.279-263.822-237.64-215.961-194.783-177.739-157.668-141.98-123.485-106.281-84.972-83.8780-38.4020
Accumulated Other Comprehensive Income/Loss -9.626-9.475-9.669-9.873-9.765-9.624-10.141-13.916-8.515-4.136-1.4890.7051.422-35.3031.961-23.531
Other Total Stockholders Equity 409.797408.154406.587405.039330.217328.593326.705325.044322.643321.285319.6651.6021.1190-36.7960
Total Shareholders Equity 96.272115.466133.162157.592104.52124.215138.854153.489172.177193.693211.924-19.654-18.3272.603-35.303-1.471
Total Equity 96.272115.466133.162157.592104.52124.215138.854153.489172.177193.693211.924-19.654-18.3272.603-35.303-1.471
Total Liabilities & Shareholders Equity 111.467128.159150.718172.553117.555136.844151.805162.157182.645202.171222.28852.03858.5342.6035.653-1.471